ARISTINE CHENGTan C.-K.Chu C.-C.YU-TSUNG HUANGLiao C.-H.WANG-HUEI SHENGPO-REN HSUEH2021-08-162021-08-1620120163-4453https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862784870&doi=10.1016%2fj.jinf.2012.02.001&partnerID=40&md5=c1f32523f07dbc2f8a4d0f05ebae60b5https://scholars.lib.ntu.edu.tw/handle/123456789/578137[SDGs]SDG3ciprofloxacin; levofloxacin; moxifloxacin; quinoline derived antiinfective agent; Acinetobacter; Acinetobacter junii; Acinetobacter lwoffii; Alcaligenes; antibiotic resistance; bacterium isolate; Burkholderia cepacia; Chryseobacterium indologenes; Chryseobacterium meningosepticum; correlation coefficient; drug use; Enterobacter cloacae; Gram negative bacterium; healthcare associated infection; human; Klebsiella pneumoniae; letter; linear regression analysis; prescription; Proteus; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pseudomonas putida; Serratia marcescens; Stenotrophomonas maltophilia; Taiwan; university hospital; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Female; Humans; Male; Urinary Tract InfectionsFluoroquinolone use and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2008letter10.1016/j.jinf.2012.02.001223430182-s2.0-84862784870